ticlopidine
The following drugs will decrease ticlopidine effect
the follwing drugs will
Increase ticlopidine effect
The follwing drugs will Increase effect by ticlopidine effect
| # | enzyme | drug | level |
| 1 | 2D6 | alprenolol | In-Vitro Only |
| 2 | 2C19 | amitriptyline | Strong inhibitor |
| 3 | 2D6 | amitriptyline | In-Vitro Only |
| 4 | 2D6 | amphetamine | In-Vitro Only |
| 5 | 2B6 | artemisinin | Strong inhibitor |
| 6 | 2C19 | atomoxetine | Strong inhibitor |
| 7 | 2D6 | atomoxetine | In-Vitro Only |
| 8 | 2D6 | brexpiprazole | In-Vitro Only |
| 9 | 2C19 | brivaracetam | Strong inhibitor |
| 10 | 2D6 | bufuralol | In-Vitro Only |
| 11 | 2B6 | bupropion | Strong inhibitor |
| 12 | 2D6 | cariprazine | In-Vitro Only |
| 13 | 2C19 | carisoprodol | Strong inhibitor |
| 14 | 2D6 | carvedilol | In-Vitro Only |
| 15 | 2C19 | celecoxib | Strong inhibitor |
| 16 | 2C19 | chloramphenicol | Strong inhibitor |
| 17 | 2D6 | chlorpheniramine | In-Vitro Only |
| 18 | 2D6 | chlorpromazine | In-Vitro Only |
| 19 | 2C19 | citalopram | Strong inhibitor |
| 20 | 2D6 | citalopram | In-Vitro Only |
| 21 | 2C19 | clobazam | Strong inhibitor |
| 22 | 2B6 | clobazam | Strong inhibitor |
| 23 | 2C19 | clomipramine | Strong inhibitor |
| 24 | 2D6 | clomipramine | In-Vitro Only |
| 25 | 2D6 | clonidine | In-Vitro Only |
| 26 | 2C19 | clopidogrel | Strong inhibitor |
| 27 | 2D6 | codeine | In-Vitro Only |
| 28 | 2C19 | cyclophosphamide | Strong inhibitor |
| 29 | 2B6 | cyclophosphamide | Strong inhibitor |
| 30 | 2D6 | debrisoquine | In-Vitro Only |
| 31 | 2D6 | desipramine | In-Vitro Only |
| 32 | 2D6 | deutetrabenazine | In-Vitro Only |
| 33 | 2D6 | dexfenfluramine | In-Vitro Only |
| 34 | 2D6 | dextromethorphan | In-Vitro Only |
| 35 | 2C19 | diazepam | Strong inhibitor |
| 36 | 2D6 | donepezil | In-Vitro Only |
| 37 | 2C19 | doxepin | Strong inhibitor |
| 38 | 2D6 | doxepin | In-Vitro Only |
| 39 | 2B6 | efavirenz | Strong inhibitor |
| 40 | 2D6 | eliglustat | In-Vitro Only |
| 41 | 2D6 | encainide | In-Vitro Only |
| 42 | 2C19 | escitalopram | Strong inhibitor |
| 43 | 2D6 | escitalopram | In-Vitro Only |
| 44 | 2C19 | esomeprazole | Strong inhibitor |
| 45 | 2D6 | flecainide | In-Vitro Only |
| 46 | 2C19 | flibanserin | Strong inhibitor |
| 47 | 2D6 | fluoxetine | In-Vitro Only |
| 48 | 2D6 | fluvoxamine | In-Vitro Only |
| 49 | 2C19 | hexobarbital | Strong inhibitor |
| 50 | 2D6 | ibrutinib | In-Vitro Only |
| 51 | 2B6 | ifosphamide | Strong inhibitor |
| 52 | 2C19 | imipramine | Strong inhibitor |
| 53 | 2D6 | imipramine | In-Vitro Only |
| 54 | 2C19 | indomethacin | Strong inhibitor |
| 55 | 2B6 | ketamine | Strong inhibitor |
| 56 | 2C19 | labetalol | Strong inhibitor |
| 57 | 2C19 | lansoprazole | Strong inhibitor |
| 58 | 2D6 | lidocaine | In-Vitro Only |
| 59 | 2C19 | mavacamten | Strong inhibitor |
| 60 | 2B6 | meperidine | Strong inhibitor |
| 61 | 2B6 | methadone | Strong inhibitor |
| 62 | 2D6 | metoclopramide | In-Vitro Only |
| 63 | 2D6 | metoprolol | In-Vitro Only |
| 64 | 2D6 | mexiletine | In-Vitro Only |
| 65 | 2D6 | minaprine | In-Vitro Only |
| 66 | 2C19 | moclobemide | Strong inhibitor |
| 67 | 2D6 | nebivolol | In-Vitro Only |
| 68 | 2C19 | nelfinavir | Strong inhibitor |
| 69 | 2B6 | nevirapine | Strong inhibitor |
| 70 | 2C19 | nilutamide | Strong inhibitor |
| 71 | 2D6 | nortriptyline | In-Vitro Only |
| 72 | 2C19 | omeprazole | Strong inhibitor |
| 73 | 2D6 | ondansetron | In-Vitro Only |
| 74 | 2C19 | ospemifene | Strong inhibitor |
| 75 | 2D6 | oxycodone | In-Vitro Only |
| 76 | 2C19 | pantoprazole | Strong inhibitor |
| 77 | 2D6 | paroxetine | In-Vitro Only |
| 78 | 2D6 | perhexiline | In-Vitro Only |
| 79 | 2D6 | perphenazine | In-Vitro Only |
| 80 | 2D6 | phenacetin | In-Vitro Only |
| 81 | 2C19 | phenobarbitone | Strong inhibitor |
| 82 | 2C19 | phenytoin | Strong inhibitor |
| 83 | 2D6 | pimavanserin | In-Vitro Only |
| 84 | 2C19 | pomalidomide | Strong inhibitor |
| 85 | 2D6 | ponatinib | In-Vitro Only |
| 86 | 2C19 | primidone | Strong inhibitor |
| 87 | 2C19 | progesterone | Strong inhibitor |
| 88 | 2C19 | proguanil | Strong inhibitor |
| 89 | 2D6 | promethazine | In-Vitro Only |
| 90 | 2D6 | propafenone | In-Vitro Only |
| 91 | 2B6 | propafol | Strong inhibitor |
| 92 | 2C19 | propranolol | Strong inhibitor |
| 93 | 2D6 | propranolol | In-Vitro Only |
| 94 | 2C19 | r-mephobarbital | Strong inhibitor |
| 95 | 2C19 | r-warfarin | Strong inhibitor |
| 96 | 2D6 | risperidone | In-Vitro Only |
| 97 | 2D6 | rucaparib | In-Vitro Only |
| 98 | 2C19 | s-mephenytoin | Strong inhibitor |
| 99 | 2B6 | selegiline | Strong inhibitor |
| 100 | 2B6 | sorafenib | Strong inhibitor |
| 101 | 2D6 | sparteine | In-Vitro Only |
| 102 | 2C19 | suvorexant | Strong inhibitor |
| 103 | 2D6 | tamoxifen | In-Vitro Only |
| 104 | 2C19 | teniposide | Strong inhibitor |
| 105 | 2D6 | tetrabenzine | In-Vitro Only |
| 106 | 2D6 | thioridazine | In-Vitro Only |
| 107 | 2D6 | timolol | In-Vitro Only |
| 108 | 2C19 | tofacitinib | Strong inhibitor |
| 109 | 2D6 | tramadol | In-Vitro Only |
| 110 | 2B6 | tramadol | Strong inhibitor |
| 111 | 2D6 | umeclidinium | In-Vitro Only |
| 112 | 2D6 | valbenazine | In-Vitro Only |
| 113 | 2B6 | velpatasvir | Strong inhibitor |
| 114 | 2C19 | venlafaxine | Strong inhibitor |
| 115 | 2D6 | venlafaxine | In-Vitro Only |
| 116 | 2C19 | vilazodone | Strong inhibitor |
| 117 | 2D6 | vilazodone | In-Vitro Only |
| 118 | 2C19 | voriconazole | Strong inhibitor |
| 119 | 2D6 | zuclopenthixol | In-Vitro Only |
will
decrease ticlopidine effect
ticlopidine will not affect
Strong inhibitor is one that causes a ≥ 5-fold decrease in the plasma AUC values or more than 80% decrease in clearance.
Moderate inhibitor is one that causes a 2 fold to < 5-fold decrease in the plasma AUC values or 50-80% decrease in clearance.
Weak inhibitor is one that causes a ≥ 1.25-fold but < 2-fold decrease in the plasma AUC values or 20-50% decrease in clearance.
In-Vitro Only In-Vitro Only Inhibitor strength.
under review Inhibitor strength level is under review.